7 unchanged sentences
Management, including our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting.
−Removed: Our internal control system was designed to provide reasonable assurance to our management and board of directors regarding the preparation and fair presentation of published consolidated financial statements in accordance with accounting principles generally accepted in the United States.
+Added: Our internal control system was designed to provide reasonable assurance regarding the preparation and fair presentation of published consolidated financial statements in accordance with accounting principles generally accepted in the United States.
Management assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2021.
−Removed: In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, in the 2013 Internal Control-Integrated Framework.
+Added: In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 Internal Control-Integrated Framework.
Based on our assessment, management has concluded the Company maintained effective internal control over financial reporting as of December 31, 2021.
2 unchanged sentences
Changes in Internal Control over Financial Reporting
+Added: There were no changes in our internal control over financial reporting during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
OTHER INFORMATION
+Added: DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
+Added: Not applicable.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
1 unchanged sentence
To the extent that we do not file the 2022 Proxy Statement by such date, we will file an amendment to this Annual Report on Form 10-K that includes the information required by this Item 10.
−Removed: We have adopted a Code of Business Conduct and Ethics that applies to all of our officers and employees (including our principal executive officer, principal financial officer, principal accounting officer or controller and other employees who perform financial or accounting functions), agents and representatives, including our independent directors and consultants, who are not employees of ours, with regard to their CareDx-related activities.
−Removed: Our Company’s Code of Business Conduct and Ethics is available on its website at www.caredx.com under the heading “Compliance” under the section titled “Company”.
−Removed: We will post on this section of our website any amendment to our Code of Business Conduct and Ethics, as well as any waivers of our Code of Business Conduct and Ethics that are required to be disclosed by the rules of the SEC or The Nasdaq Stock Market LLC.
EXECUTIVE COMPENSATION
27 unchanged sentences
10-Q 001-36536 3.1 8/28/2014
+Added: 3.2 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of CareDx, Inc., filed June 17, 2021.
+Added: 8-K 001-36536 3.1 6/21/2021
3.3 Amended and Restated Bylaws of the Registrant.
−Removed: 10-Q 001-36536 3.4 8/28/2014
−Removed: 4.1 Form of Registrant’s common stock certificate.
8-K 001-36536 3.2 6/21/2021
−Removed: 4.2# 2014 Equity Incentive Plan and forms of agreements, as amended.
+Added: 4.1 Form of Registrant’s common stock certificate.
10-K 001-36536 4.1 3/31/2015
+Added: 4.2# 2014 Equity Incentive Plan, as amended.
+Added: 10-Q 001-36536 4.2 7/29/2021
4.3# Form of Option Agreement under the 2014 Equity Incentive Plan for New Options.
3 unchanged sentences
4.5# 2016 Inducement Equity Incentive Plan.
−Removed: S-8 333-211538 4.1 5/23/2016
+Added: 10-Q 333-211538 4.5 7/29/2021
4.6 Form of Warrant.
1 unchanged sentence
4.7# 2019 Inducement Equity Incentive Plan.
−Removed: 8-K 001-36536 10.1 9/4/2019
+Added: 10-Q 001-36536 4.7 7/29/2021
4.8* Description of Securities of CareDx, Inc.
19 unchanged sentences
10.10# Outside Director Compensation Policy.
−Removed: 10.11 Lease, dated April 27, 2006, as amended on November 10, 2010, by and between the Registrant and BMR-Bayshore Boulevard LLC, for office and laboratory space located at 3260 Bayshore Boulevard, Brisbane, California 94005.
−Removed: S-1 333-196494 10.12 6/3/2014
+Added: 10-K 001-36536 10.10 2/28/2020
Incorporated by Reference
1 unchanged sentence
Exhibit Filing Date
+Added: 10.11 Lease, dated April 27, 2006, as amended on November 10, 2010, by and between the Registrant and BMR-Bayshore Boulevard LLC, for office and laboratory space located at 3260 Bayshore Boulevard, Brisbane, California 94005.
+Added: S-1 333-196494 10.12 6/3/2014
10.12+ Second Amendment to Lease, dated January 2, 2020, by and between the Registrant and BMR-Bayshore Boulevard LP (formerly known as BMR-Bayshore Boulevard LLC), for office and laboratory space located at 3260 Bayshore Boulevard, Brisbane, California 94005.
10 unchanged sentences
10-Q/A 001-36536 10.3 10/9/2018
+Added: 10.17# Offer Letter, dated February 11, 2021, between CareDx, Inc.
+Added: and Ankur Dhingra.
+Added: 8-K 001-36536 10.1 3/11/2021
+Added: 10.18# Promotion Letter, dated July 12, 2021, between CareDx, Inc.
+Added: and Alex Johnson.
+Added: 8-K 001-36536 10.1 7/20/2021
21.1* Subsidiaries of the Registrant.
27 unchanged sentences
POWER OF ATTORNEY
−Removed: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Reginald Seeto and Marcel Konrad, and each of them, his true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
+Added: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Reginald Seeto and Ankur Dhingra, and each of them, his true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons, on behalf of the registrant on the dates and the capacities indicated.
4 unchanged sentences
Reginald Seeto, MBBS
−Removed: /s/ MARCEL KONRAD Interim Chief Financial Officer
+Added: /s/ ANKUR DHINGRA Chief Financial Officer
(Principal Financial and Accounting Officer)
February 24, 2022
−Removed: Marcel Konrad
+Added: Ankur Dhingra
/s/ PETER MAAG, PH.D.
−Removed: Executive Chair and Director February 24, 2021
+Added: Director February 24, 2022
Peter Maag, Ph.D.
12 unchanged sentences
William Hagstrom
+Added: /s/ HANNAH VALANTINE Director February 24, 2022
+Added: Hannah Valantine
+Added: /s/ ARTHUR TORRES Director February 24, 2022
+Added: Arthur Torres
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.